News
Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design
Merck appreciates the U.S. Food and Drug Administration's (FDA) recognition of our efforts to create new standardized product packaging for several of our medicines. These changes to the packaging of several medicines were made by Merck...
News
Synthes and Lilly Sign Development and Collaboration Agreement
Synthes, Inc. and Eli Lilly and Company announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures. ...
News
Forest Laboratories, Inc. Announces Availability of Daliresp(TM) in Pharmacies
Forest Laboratories, Inc. announced today that Daliresp(TM) (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk...
News
Novagali Pharma and Ardeo sign an exclusive distribution agreement for Nova23041
Novagali Pharma, a pharmaceutical company that develops innovative ophthalmic products, can today announce that it has signed an exclusive agreement with Ardeo Health, LLC for Nova23041 its unique formulation for thetreatment of dry eye symptoms in the United States...
News
Kuecept present at Procept Spray Drying seminar in Barcelona
Kuecept were pleased to be invited to present their latest research in the field of spray drying at the Procept Spray Drying Seminar held in Barcelona on the 8th June. With over 50 attendees from more than 15 organisations...
News
Biogen Idec Receives Approval in the European Union for AVONEX(R) PEN
Biogen Idec announced that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event. Douglas E. Williams, Ph.D.,...
News
Dr. Reddy’s announces three generic product launches in the US Market
Dr. Reddy’s Laboratories announced that it has launched the following three products in the US market: Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version of ARICEPT® tablets*. The Food & Drug Administration (FDA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
